Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration

CapsCanada
 
K2VITAL®
Bifidobacterium, bacterial strain3d illustration. Bifidobacterium, bacterial strain3d illustration.

The DuPont Human Microbiome Venture (Copenhagen, Denmark) has announced a research partnership with The Procter & Gamble Company (P&G, Cincinnati, OH), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health.

Over the past years, both P&G and DuPont have conducted extensive research on human commensals to help address metabolic health issues in humans. In order to accelerate the development and commercialization of NGPs, both companies are joining forces to develop NGPs, initially to be used in dietary supplements.

There is an increasing number of studies that have shown that diet and poor lifestyle choices negatively affect the gut microbiota which can result in chronic low-grade inflammation which is closely associated with the onset and prevalence of metabolic health related conditions. On the contrary, increasing levels of certain anaerobic bacteria in the gut has been shown to increase insulin sensitivity and thus helps to maintain healthy blood sugar levels.

“It’s an exciting opportunity to partner with P&G to jointly develop the next generation of microbe-based products. The combination of DuPont’s and P&G’s unique set of capabilities will allow us to accelerate innovation in the field of metabolic health and help millions of consumers affected by metabolic health issues,” said Sebastien Guery, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

“As a company focused on innovation, P&G is excited to come together with our valued partners at DuPont. Many consumers trust Align, the No. 1 doctor and gastroenterologist recommended probiotic brand, to promote and support a healthy digestive system.* This strategic partnership will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world,” said Paul Gama, president, P&G Personal Health Care.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. 

For more information, visit www.pg.com, www.dupontnutritionandbiosciences.com or www.dupont.com.

 

K2VITAL®
 
Albion Minerals®